At a glance
ClinicalIndex Comparison RecordN/ACompleted· 45 enrolled
Drug / intervention
OsseoSpeed™ TX implant (Ø 4.0 mm, length 6 mm)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open, Prospective, Multi-center Study Assessing the OsseoSpeed™ TX Length 6 mm in in the Posterior Maxilla and Mandible. A 3-years Follow-up Study.
In Brief
A clinical study evaluating OsseoSpeed™ TX implant (Ø 4.0 mm, length 6 mm) for Partially Edentulous Jaw. Completed, enrolled 45 participants across 3 sites.
Detailed Summary
The purpose of this study is to investigate the clinical efficacy of OsseoSpeed™ TX 6 mm implants in a Chinese population by evaluation of marginal bone level alteration, implant stability and implant survival in the posterior mandible and maxilla up to 3 years after loading. The hypothesis is that one stage surgery using 6 mm OsseoSpeed™ TX implant in the posterior region is safe and predictable.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPartially Edentulous Jaw
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2011
First PostedMay 2011
Primary CompletionMar 2016
TodayJul 2026
First PostedMay 3, 2011
Enrollment StartFeb 1, 2011
Primary CompletionMar 1, 2016
TodayJul 2, 2026
Enrollment to primary: 5.1 yearsPosted 15.2 years ago
Interventions
OsseoSpeed™ TX implant (Ø 4.0 mm, length 6 mm)device